S-100B and Neuron-specific Enolase (NSE) in Spinal Trauma

Completed

• Conditions: Spinal Cord Injury

• Registration Number: NCT00980434
• Lead Sponsor: Medical University of Vienna

Brief Summary

The investigators are studying the clinical worth of the serum markers S-100B and NSE in patients with spinal cord injuries e.g. in patients with vertebral fractures. If there is a injury to the neuronal structures these two proteins could be secreted into the serum and add evidence to the severity of the injury.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-02
• Study First Submitted: 2009-09-18
• Study First Submitted QC: 2009-09-18
• Study First Posted: 2009-09-21
• Status Verified: 2011-07
• Primary Completion: 2011-11
• Study Completion: 2011-12
• Last Update Submitted: 2012-04-03
• Last Update Posted: 2012-04-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• vertebral fracture
• injuries to the vertebral spine

Exclusion Criteria

• head trauma
• polytrauma

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Neurological Symptoms	2 weeks

Trial Locations

Locations (1)

Medical University of Vienna; 🇦🇹 Vienna, Austria